United States Antimony Corp
5 nominees · 5 ballot items.
Five proposals are being voted on: (1) Election of five directors for one-year terms; (2) Reincorporation of the company from Montana to Texas by conversion; (3) Adoption of Amended and Restated 2023 Equity Incentive Plan; (4) Advisory vote on executive compensation; (5) Ratification of Assure CPA, LLC as the company's independent auditor for 2025.
Follow how the vote landed and what changed on United States Antimony Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot5
- 1
Election of Directors
ManagementBoard: FORElect five directors named in the Proxy Statement for a one-year term; Board recommends FOR all nominees.
- 2
Texas Reincorporation Proposal
ManagementBoard: FORApprove the Plan of Conversion to Texas and related Plan of Conversion; Board recommends FOR.
- 3
Adoption of Amended and Restated 2023 Equity Incentive Plan
ManagementBoard: FORAdopt the Amended and Restated 2023 Equity Incentive Plan; increase the aggregate shares available for awards by about 15,000,000.
- 4
Advisory Vote Approving Executive Compensation
ManagementBoard: FORAdvisory (non-binding) vote on executive compensation for named executive officers.
- 5
Ratification of Selection of Independent Auditor
ManagementBoard: FORRatify the appointment of Assure CPA, LLC as the Company's independent auditor for 2025.
Nominees on the ballot5
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VAN ECK ASSOCIATES CORP | 7.0% | 10,369,695 | $91M |
| 2 | STATE STREET CORP | 5.4% | 8,047,077 | $70M |
| 3 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.6% | 5,345,710 | $47M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 5,200,486 | $45M |
| 5 | BlackRock, Inc. | 3.2% | 4,802,076 | $42M |
| 6 | BlackRock, Inc. | 2.5% | 3,717,097 | $32M |
| 7 | Hood River Capital Management LLC | 1.9% | 2,759,376 | $24M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 2,301,006 | $20M |
| 9 | AMERIPRISE FINANCIAL INC | 1.4% | 2,067,340 | $18M |
| 10 | UBS Group AG | 1.2% | 1,839,172 | $16M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at United States Antimony Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the United States Antimony Corp 2025 annual meeting?
- United States Antimony Corp (UAMY) holds its 2025 annual shareholder meeting on Thursday, July 31, 2025.
- What is the record date for the United States Antimony Corp 2025 meeting?
- The record date for the United States Antimony Corp 2025 meeting is Friday, June 6, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for United States Antimony Corp's 2025 meeting?
- The board is presenting 5 director nominees at the United States Antimony Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the United States Antimony Corp 2025 meeting?
- Shareholders will vote on 5 proposals at the United States Antimony Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.